Skip to content
25–27 October 2027 · Orlando

Scientific Program · Diabetes 2022

Diabetes 2022 — Scientific Program

Day-by-day session and presentation schedule

The full Diabetes 2022 scientific program across 2 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Keynote

    Heart failure management; a perspective from diabetes care

    Baruch Itzhak · Tel Aviv University, Israel

    People with type 2 diabetes (T2DM) are recognized as having a 2–4 times increased risk of heart failure (HF). Ambulatory diabetes care has long concentrated on the prevention of microvascular and arterial disease, and…

  2. Oral · In-Person

    Epidemiological profile of diabetes, northeast, Haiti, 2017-2021

    Kensly Flecher · Field Epidemiology Training Program (FETP), Haiti

    Background : According to the WHO, diabetes is a public health problem. Its prevalence continues to increase over the years. The number of cases has increased worldwide from 108 million in 1980 to 537 million in 2021.…

  3. Oral

    Role of the abscisic acid/LANCL system in glycemic control: A promising aid to combat diabetes and related metabolic syndrome

    Laura Sturla · University of Genova, Italy

    Abscisic acid (ABA) is an isoprenoid hormone with a very long evolutionary history and the only known hormone common to the vegetal and animal kingdoms, with a conserved role as a signal regulating cell responses to…

  4. Oral

    Gestational diabetes is associated with a distinct urinary metabolomic signature in the latter half of pregnancy

    Aisling Murphy · University of California, United States

    Introduction: Gestational diabetics (GD) have both impaired insulin sensitivity and secretion, which may lead to perturbations in multiple metabolic pathways. Currently, screening paradigms for gestational diabetes…

  5. Oral

    Microsomal triglyceride transfer protein regulates intracellular lipolysis in adipocytes independent of its lipid transfer activity

    Sujith Rajan · NYU Long Island School of Medicine, United States

    Background: The triglyceride (TG) transfer activity of microsomal triglyceride transfer protein (MTP) is essential for lipoprotein assembly in the liver and intestine; however, its function in adipose tissue, which does…

Day 2

Day 2

  1. Keynote

    Metal ion dyshomeostasis and coagulatory defects in diabetes

    Alan J Stewart · University of St. Andrews, United Kingdom

    Diabetes is a term used to describe a group of conditions that impact upon the body’s ability to control blood glucose levels. In type-I diabetes (T1DM), the β-cells in the pancreas responsible for producing insulin are…

  2. Keynote

    Indicaxanthin from opuntia ficus indica fruit ameliorates glycidic metabolism and counteracts insulin resistance in high-fat-diet-fed mice

    Mario Allegra · University of Palermo, Italy

    Dysmetabolic conditions related to insulin-resistance (IR) are amongst the most common cause of death globally and their primary prevention has become a compelling goal of public health-oriented strategies. In recent…

  3. Keynote

    Blood sugar fasting, post prandial and HbA1c level co-relationship in the management of diabetes mellitus.

    Ashok Sharma · Indraprastha Apollo Hospital, India

    Objectives There are only three main markers for the diagnosis and management of diabetes Mellitus. Fasting and post prandial blood sugar level gives the amount of glucose present during single point of time. On the…

  4. Keynote

    Computer assisted quantifiable diagnostic tool for diabetic retinopathy

    Jan Nemcansky · Charles University, Czech Republic

    Rising prevalence of diabetic retinopathy (DR) and diabetic macular edema represents significant burden in the society and raises challenges both in establishing effective screening and in enlargening the screening…

  5. Keynote

    Functional roles of dietary fibres from selected agricultural by-products in lowering glycemic index values of foods

    Wan Rosli Wan Ishak · Universiti Sains Malaysia, Malaysia

    Statement of the Problem: Presently, the prevalence of non-communicable diseases is increasingly growing with the number of diabetic people expected to increase from 171 million in 2000 to 366 million in 2030. This is…

  6. Oral

    Activity tracker to increase motivation for physical activity in patients with Type 2 diabetes in primary care: A hybrid type 1 study

    Caroline Rheaume · Laval University, Canada

    According to the World Health Organization, diabetes is the direct cause of 1.5 million deaths annually. The adoption of healthy lifestyles, such as regular and consistent physical activity, plays an important role in…

  7. Oral

    Advanced course: GLP-1 agonists - The future of diabetes research and clinical treatments

    William A Seeds · SSRP Institute, United States

    Heart disease remains the number leading cause of death year after year. The increased risk factors are certainly related to cardiovascular conditions but are also significantly attributable to metabolic disease states.…

  8. Oral

    Diabetes management in spinal surgery

    Brandon Lucke Wold · University of Florida, United States

    Diabetes mellitus can lead to long-standing complications in multiple arenas. An area that is often overlooked is implications for major surgery. Spinal decompression and fusions have unique challenges in the diabetic…

  9. Oral

    Metformin, pioglitazone, liraglutide and exenatide differentially affect metabolic and hormonal profiles in polycystic ovary syndrome: Cross-sectional study

    Wenjing Hu · Chongqing Prevention and treatment Hospital for Occupational Diseases, China

    Background and aims: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting up to 13% of women of reproductive age. Although the underlying pathogenesis of PCOS has not been fully understood…

  10. Oral

    An insight view on herbal and alternative remediesused in the treatment of diabetes mellitus

    Rupesh K Gautam · Amity Institute of Pharmacy, India

    Diabetes is a major public health concern that has been progressively rising worldwide. This disease is associated with a high rate of mortality, morbidity, and long-term consequences and remains a significant risk…

  11. Oral

    Epidemiological profile of diabetes in the south department from 2015 to 2021, Haiti

    Berger Saintius · Field Epidemiology Training Program (FETP), Haiti

    Background: Diabetes is an incurable chronic disease caused by a deficiency or failure to use insulin leading to excess sugar in the blood. According to the WHO, diabetes remains a real public health problem, despite…

  12. Oral

    Statistical profile of new case of diabetes in the department of grand'anse 2020-2022, Haiti

    Olguine Artiste · Field Epidemiology Training Program (FETP), Haiti

    Diabetes sweet is defined by elevation chronicle of the concentration of glucose in the blood, to fasting 1.26 g/L or > 2g / L whatever collection time in presence of symptoms clinics, there are 2 types of diabetes…

  13. Oral

    Serum haptoglobin is associated with obesity and lipids in mexicans

    Miguel Vazquez Moreno · Mexican Social Security Institute, Mexico

    Background . Haptoglobin is an acute-phase inflammatory protein mainly produced by the liver. Although recent literature evidence that rs2000999 in the HP gene is associated with total cholesterol (TC) and low-density…

  14. Poster

    Endocrinological teleconsultation as a strategy in the brazilian public health system: randomized clinical trial

    Daniela Laranja Gomes Rodrigues · Hospital Alemão Oswaldo Cruz, Brazil

    Brazil has approximately 20 million people with Diabetes Mellitus. Early identification and treatment should be a concern of public authorities, to improve glycemic control and reduce it`s deleterious impacts on the…

  15. Poster

    Reducing blood sugar level by ascending or descending the hexose sugar into nontoxic high or low carbon sugars or through superimposing glucose mirror image sugars by shaking it into a 12 carbon sugar, in vivo

    Ravi Kikar Sinha · Indian Private Researcher, India

    Organic Chemists and Biochemist's attention is brought to the task of searching for enzymes and procedures to affect in vivo enzymatic ascending or descending glucose sugars into nontoxic high or low carbon sugars or in…

Present your research at Diabetes 2027

Abstract submissions for the 2027 program are open · October 25–27, 2027 · Double Tree by Hilton Orlando Downtown, Orlando.

Submit Abstract →

Join the Diabetes 2027 delegation

Orlando · October 25–27, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.